



























Link to publication record in King's Research Portal
Citation for published version (APA):
Miller, T. H., Ng, K. T., Bury, S., Bury, S., Bury, N. R., & Barron, L. P. (Accepted/In press). BIOMONITORING OF
PESTICIDES, PHARMACEUTICALS AND ILLICIT DRUGS IN A FRESHWATER INVERTEBRATE TO
ESTIMATE TOXIC OR EFFECT PRESSURE. Environment International.
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. May. 2019
1 
 
BIOMONITORING OF PESTICIDES, PHARMACEUTICALS AND ILLICIT DRUGS 1 
IN A FRESHWATER INVERTEBRATE TO ESTIMATE TOXIC OR EFFECT 2 
PRESSURE  3 
Thomas H. Millera*, Keng Tiong Nga, Samuel T. Buryb, Sophie E. Buryc, Nicolas R. 4 
Buryd,e†, Leon P. Barrona† 5 
 6 
aDepartment of Analytical, Environmental & Forensic Sciences, School of Population 7 
Health & Environmental Sciences, Faculty of Life Sciences and Medicine, King’s 8 
College London, 150 Stamford Street, London, SE1 9NH, UK. 9 
bSt Olaves Grammer School, Goddington Lane, Orpington, BR6 9SH, UK 10 
cDepartment of Pyschology, Royal Holloway, University of London, Egham, Surrey 11 
TW20 0EX, UK 12 
dSchool of Science, Technology and Engineering, University of Suffolk, James Hehir 13 
Building, University Avenue, Ipswich, Suffolk, IP3 0FS, UK. 14 
eSuffolk Sustainability, University of Suffolk, Waterfront Building, Neptune Quay, 15 
Ipswich, IP4 1QJUK. 16 
 17 
†Principal Investigators 18 
*Corresponding author 19 














Abstract  27 
Multiple classes of environmental contaminants have been found in aquatic 28 
environments, globally. Understanding internalised concentrations in the organism 29 
could further improve the risk assessment process. The present study is concerned 30 
with the determination of several contaminant classes (107 compounds) in Gammarus 31 
pulex collected from 15 sites covering 5 river catchments across Suffolk, UK. 32 
Quantitative method performance was acceptable for 67 compounds including 33 
pharmaceuticals, pesticides, illicit drugs and drugs of abuse. A total of 56 compounds 34 
were detectable and ranged from <LOQ to 45.3 ng g-1, with cocaine and lidocaine 35 
being the most frequently detected compounds present in all biota samples (n=66). 36 
For surface water, 50 compounds were detectable and ranged from <LOQ to 382.2 37 
ng L-1. Additionally, some pesticides currently not approved for use were detected, 38 
including fenuron that reached a maximum of 16.1 ng g-1. The internal concentrations 39 
of pesticides were used to estimate toxic pressure which showed that for the measured 40 
pesticides toxic pressure was low ranging from logTU ≤-7 to ≤-2. This methodology 41 
was extended to pharmaceuticals and drugs of abuse in a novel approach that 42 
proposed the use of pharmacological data (human therapeutic plasma concentrations) 43 
to estimate the likelihood of an effect (or effect pressure) to occur based on the internal 44 
exposure of the organism. The quantified effect pressure ranged from logEU ≤-9 to ≤1 45 
with haloperidol showing the largest likelihood for an effect. The approach showed that 46 
several pharmaceuticals have the potential to elicit effects but further investigation 47 
surrounding thresholds for effects would be required. This new approach presented 48 
showed potential to be used to improve risk assessment for pharmaceuticals in the 49 
environment.  50 
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1. Introduction 53 
The contamination of the aquatic environment has been the focus of many 54 
investigations and many issues have been identified with respect to a number of 55 
classes of compounds including pharmaceuticals [1] and plant protection products 56 
(pesticides) [2] Within each class, adverse effects of some specific contaminants on 57 
biota have been well studied, although effects and/or associated risks are often 58 
derived based on exposure concentration levels measured external to the organism 59 
(e.g., in water or sediment). A reason for this is that the determination of trace 60 
contaminants in biota has traditionally been very challenging, not only in terms of the 61 
analytical selectivity required to reliably separate hundreds of different compounds but 62 
to do so quantitatively at trace concentrations (e.g. pg-ng g-1) [1]. However, advances 63 
in analytical workflows have now enabled trace quantitative measurements in complex 64 
biological matrices such that internalised contaminant concentrations can be used to 65 
set thresholds for effects [3-5].  66 
Arguably, routine determination of internalised concentrations of 67 
pharmaceuticals in particular is still critically lacking [1]. This is also true for some other 68 
contaminant classes such as illicit drugs. Additionally, neonicotinoid insecticides, 69 
which are largely used on land and have rarely been targeted for measurement in 70 
aquatic fauna except for a small number of recent studies in fish and invertebrates [6-71 
8]. However, other pesticides have been more routinely monitored in aquatic biota, 72 
such as organochlorine insecticides, which are reported at the low to mid ng g-1 range 73 
in both vertebrates and invertebrates [9, 10]. This is likely due to extensive regulation 74 
of these types of contaminants following seminal research in the 1950s (e.g., with 75 
dichlorodiphenyltrichloroethane (DDT) [11]) to the more recent Stockholm Convention 76 
treaty on persistent organic pollutants which cover many other such compounds [12].  77 
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Previous studies have used the Species at Risk (SPEAR) index [13, 14] to 78 
relate the ‘toxic pressure’ of pesticides in agricultural catchments to the impact on 79 
invertebrate communities and is quantified in toxic units (TU) [15]. The TU is derived 80 
from the ratio between the measured concentration of the contaminant in surface 81 
water and known toxicity data, such as the LC50. Recently, the TU approach has been 82 
applied using internal pesticide concentration measurements and predicted EC50 83 
values [6]. Aside from pesticides, this approach could also be extended for other 84 
contaminant types such as pharmaceuticals. This would prove particularly useful as it 85 
would provide an estimate of risk, based on both measured concentrations and effect 86 
data. This has already been performed for selected pharmaceuticals in the Antarctic 87 
peninsula [16]. However, a significant barrier to wider application is that there is a 88 
paucity of effect data for pharmaceuticals and reported EC50 data can vary 89 
considerably [17]. Other approaches such as the use of critical environmental 90 
concentrations (CECs) proposed by Fick et al. [18], which are based on the fish plasma 91 
model [19], could be a useful alternative to the use ecotoxicity endpoint data.  92 
The aim of this work was to determine the extent of contaminant occurrence 93 
and to estimate the toxic pressure of pesticides and extend this approach to 94 
pharmaceuticals, drugs of abuse and illicit drugs to determine an ‘effect pressure’ 95 
across several watercourses in Suffolk. This was achieved through the development 96 
of an extended analytical methodology to reliably quantify several classes of 97 
contaminants in both surface waters and a freshwater invertebrate species 98 
(Gammarus pulex). Samples were collected from 15 sites covering five river 99 
catchments and used to estimate toxic/effect pressure. Internalised concentrations 100 
determined herein and a previously developed model for prediction of bioconcentration 101 
factors in G. pulex [20] along with the well-established EPISuite [21] BCF predictions 102 
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in fish were used to calculate internal toxic units (TUint) and effect units (EUint) for 103 
pesticides and pharmaceuticals, respectively.   104 
 105 
2. Materials and Methods 106 
2.1 Reagents, chemicals and consumables 107 
HPLC grade methanol, acetonitrile, and LC-MS grade (Optima™) ammonium acetate 108 
were purchased from Fischer Scientific (Loughborough, UK). A total of 141 109 
compounds were used in this study (see Supplementary Information (SI)). Of these, 110 
85 were pharmaceuticals/illicits, 22 were pesticides and 34 were stable isotopically 111 
labelled internal standards (SIL-IS). All analytical standards were of a purity of ≥ 97%. 112 
Ultra-pure water was obtained from a Millipore Milli-Q water purification system with a 113 
specific resistance of 18.2 MΩ cm or greater (Millipore, Bedford, MA, USA). Stock 114 
solutions (1 mg mL-1) were prepared in methanol or acetonitrile and stored in silanised 115 
amber vials (20 mL). Working solutions were prepared daily in ultra-pure water, as 116 
required. All solutions were stored at -20 °C and in the dark to reduce possible 117 
degradation. 118 
 119 
2.2 Sample collection  120 
Samples were collected in July 2018. Locations were chosen based on previous 121 
Environment Agency sampling sites in catchments of the river Alde, Waveney, Stour, 122 
Gipping and Deben (Figure 1). Macroinvertebrates were collected by kick sampling 123 
into a 250 µm net. G. pulex was present at all sites except the River Box in the Stour 124 
catchment and one site on the River Waveney, where the most abundant 125 
macroinvertebrate Ephemera vulgata (larvae) and Asellus aquaticus was sampled 126 
instead. At the site on the river Gipping, G.pulex numbers were low and the caddis fly 127 
8 
 
Hydropyshe pellucidula (larvae) were also sampled. Macroinvertebrates were sorted 128 
on site, excess water removed by tissue paper and immediately frozen on dry ice. 129 
Samples were kept at -80 oC prior to processing. Water pH and temperature were 130 
measured (Table S3) and a 500 mL water sample taken, acidified (0.1% HCl) and 131 
stored at 4 oC for a maximum of 4 days prior to analysis to improve stability of analytes 132 
as shown in previous studies [22, 23].  133 
 134 
2.3 Sample preparation  135 
Prior to extraction, frozen G. pulex samples were lyophilised at -50 °C under vacuum 136 
for 24 h. Pooled samples of 5-6 organisms were placed into 2 mL Eppendorf tubes 137 
with a 3 mm diameter tungsten carbide bead and subsequently ground into a fine 138 
powder using a TissueLyser LT (Qiagen, Hilden, Germany) set at 50 Hz for 5 min. 139 
Freeze-dried composite samples of G. pulex material (20 mg) were transferred to a 140 
new 2 mL Eppendorf tube with any necessary spiking of standards or SIL-IS carried 141 
out directly onto the solid matrix using a 100 μL volume of an appropriate working 142 
solution before proceeding with the extraction. A 2 mL volume of 3:1 (MeCN:H2O) 143 
acidified with 0.1% (v/v) glacial acetic acid was added to the material and agitated for 144 
5 min at 50 Hz in the Tissuelyser LT. The samples were then placed in an ultrasonic 145 
bath for 15 min followed by centrifugation for 5 min at 14,000 rpm to pellet insoluble 146 
particulate matter. Following extraction and settling, an aliquot of the supernatant (1.9 147 
mL) was diluted to 100 mL with 10 mM ammonium acetate in ultra-pure water (pH 148 
6.5). Tandem solid phase extraction (SPE) was then carried out on the diluted sample 149 
using a Strata Alumina-N cartridge (6 mL, 1 g, Phenomenex Ltd., Cheshire, UK) 150 
coupled to an Oasis HLB cartridge (6 mL, 200 mg, Waters Corp., Hertfordshire, UK). 151 
Tandem SPE was utilised to remove interfering pigments and lipids (alumina) and pre-152 
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concentrate target analytes (HLB). Before loading of the sample, the combined SPE 153 
cartridges were first conditioned with 6 mL of methanol and 6 mL of ultra-pure water 154 
with 10 mM ammonium acetate. After sample loading, both cartridges were then 155 
washed with 1 mL ultra-pure water and dried for ~30 min under vacuum. Cartridges 156 
were then stored at -20 °C until analysis. Cartridges were eluted with 5 mL MeOH and 157 
dried under pure nitrogen (1.0 bar) at 35 °C using a TurboVap LV (Biotage, Uppsala, 158 
Sweden). Extract residues were reconstituted in 0.1 mL 90:10 (v/v) 10 mM ammonium 159 
acetate in H2O:MeCN (optimised). Surface water samples were filtered through a 0.45 160 
µm glass-fibre filter and split into three aliquots (100 mL). Surface water samples then 161 
underwent SPE and reconstitution as described above, but without use of the Strata 162 
Alumina-N cartridges (as pigments were not problematic). Any necessary spiking or 163 
liquid volume measurements were carried out using positive displacement pipettes 164 
(Gilson Microman, Villiers-le-Bel, France). 165 
 166 
2.4 Instrumental analysis and conditions 167 
Briefly, liquid chromatography (LC) was performed on a Vanquish series LC system 168 
(ThermoFisher Scientific, Hemel Hempstead, UK) using a Waters SunFire C18 column 169 
(3.5 μm, 2.1 mm × 150 mm, Waters Corp., Milford, MA, USA) with a KrudKatcher™ 170 
Ultra pre-filter (0.1 mm ID, 0.5 μm filter, Phenomenex, Macclesfield, UK) and a Sunfire 171 
C18 VanGuard Cartridge (3.5 μm, 2.1 mm x 5 mm) at a flow rate of 0.3 mL min-1 and 172 
an injection volume of 20 μL. Mobile phases were 90:10 (v/v) 10 mM ammonium 173 
acetate in H2O:MeCN (A) and 20:80 (v/v) 10 mM ammonium acetate in H2O:MeCN 174 
(B). The gradient elution profile followed a linear ramp of mobile phase B which 175 
increased to 10 % at 1 min, 35 % at 5.6 min, 40 % at 7 min, 50 % at 8 min and 100 % 176 
at 11 min and was held for a further 11 min before returning to initial conditions. Re-177 
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equilibration time was 3 min resulting in an overall run time of 25 min. Detection and 178 
quantification was carried out with a TSQ Vantage triple quadrupole mass 179 
spectrometer (Thermo Fisher Scientific, Hemel Hempstead, UK) equipped with an 180 
atmospheric pressure interface–heated electrospray ionisation (API-HESI-II) source. 181 
Mass spectrometry (MS) was performed in selected reaction monitoring (SRM) mode 182 
using positive–negative ionisation polarity switching. See the SI for full details of 183 
analytical conditions and method performance testing procedures.  184 
 185 
2.6 Estimation of toxic and effect pressure 186 
Toxic pressure was calculated according to Munz et al. [6] using toxic units (TU) to 187 
estimate the internal toxic pressure of pesticides. The internal toxic unit (TUint) or effect 188 
unit (EUint) used here is defined by equations 1-3. 189 
 190 
𝐸𝐶50𝑖𝑛𝑡 = 𝐸𝐶50 × 𝐵𝐶𝐹 (1) 191 
𝑇𝑈𝑖𝑛𝑡 =  
𝐶𝑖
𝐸𝐶50𝑖𝑛𝑡
 (2) 192 
𝐸𝑈𝑖𝑛𝑡 =  
𝐶𝑖
𝐶𝐸𝐶
   (3) 193 
Where, EC50int is the internal concentration which affects 50% of the population; EC50 194 
is the exposure medium concentration affecting 50% of the population; BCF is the 195 
bioconcentration factor; Ci is the concentration of contaminant determined in the 196 
organism. For pesticides, available EC50 values (48 h acute in Daphnia magna) 197 
available from the Pesticide Properties Database [24]. The BCFs were estimated from 198 
both EPI Suite BCFBAF v3.02 [21] software and our own previously developed 199 
artificial neural network (ANN) for prediction of BCFs in G. pulex [20] (Figure 2). The 200 
comparison of the predicted BCFs between both approaches showed relatively good 201 
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agreement for most cases (see Table S4 and Figure S1) and overall were not 202 
statistically significant (p-value = 0.36).  203 
For pharmaceuticals, drugs of abuse and illicit drugs, EC50 values were substituted 204 
(due to lack of available data) with CECs [18]. Here, the CEC is the estimated surface 205 
water concentration that will give rise to a fish plasma concentration equivalent to the 206 
human therapeutic plasma concentration (Equation 4). Thus, it would be expected and 207 
assumed that if drug targets are conserved, an effect would be elicited.  208 
𝐶𝐸𝐶 =  
𝐻𝑇𝑃𝐶
(𝐶𝑅 × 𝑃𝑏𝑙𝑜𝑜𝑑:𝑤𝑎𝑡𝑒𝑟)
   (4)  209 
Where, HTPC is the human therapeutic plasma concentration (µg mL-1), CR is the 210 
concentration ratio between the human therapeutic plasma concentration and the fish 211 
steady-state plasma concentration (assumed to be 1 herein), Pblood:water is the partition 212 
coefficient of a compound between blood and water.  213 
 214 
3. Results and Discussion 215 
3.1 Method performance 216 
Method performance was assessed in G. pulex to ensure that the method could 217 
reliably quantify targeted analytes at the low ng g-1 concentration level (Table 1). A 218 
total of 107 compounds were assessed and 67 compounds (55 pharmaceuticals and 219 
12 pesticides) were deemed acceptable for quantification purposes with the remaining 220 
analytes suitable for qualitative analysis (according to ICH guidelines). A t-test 221 
assuming unequal variances showed that there was no significant difference between 222 
the performance of the method for either pharmaceuticals or pesticides in terms of 223 
recovery and precision (p > 0.05). The method showed good sensitivity for trace-224 
analysis with LOQs ranging from 0.09 – 25.2 ng g-1 (median: 1.7 ng g-1) dry weight 225 
and LODs as low as 0.03 ng g-1 (median: 0.6 ng g-1) dry weight. The sensitivity of the 226 
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method was comparable to others that have determined pharmaceuticals and 227 
pesticides in invertebrates. For example, Inostroza et al., had method quantification 228 
limits (MQLs) of 0.01-2.13 ng g-1 wet weight [4], Althakafy et al., reported detection 229 
limits ranging 0.04 – 2.38 ng g-1 wet weight [25] and Munz et al., achieved LOQs of 230 
0.1 to 9 ng g-1 wet weight [6]. Linearity was acceptable (R2 >0.98) and the 231 
chromatographic separation showed good reproducibility with an average standard 232 
deviation in retention time of ±0.015 min (n = 5). The repeatability of the method was 233 
also acceptable with average intra-day imprecision of 9±5%, 9±4% and 8±4% at three 234 
different concentrations of 25, 50 and 100 ng g-1 dry weight. Inter-day precision 235 
determined at 50 ng g-1 across three days showed slightly lower precision but was still 236 
considered acceptable (average 14±4%) and was perhaps due to the inhomogeneity 237 
of such small samples and different operators between days. Absolute recoveries of 238 
the method ranged from 26 – 100 % (average: 74 %)  and is in line with a recent study 239 
that focussed on quantification of both pharmaceuticals and pesticides in G. pulex 240 
where recovery ranged from 9 – 70% [6]. Method accuracy averaged 92 ±10 %, 97 241 
±12 % and 104 ±9 % compared to the expected nominal concentration at 25, 50 and 242 
100 ng g-1.  243 
 244 
3.2 Biomonitoring of emerging contaminants across Suffolk catchments  245 
Occurrence studies are often focussed on the determination of contaminant 246 
concentrations in surface water samples and other abiotic matrices such as 247 
wastewater and sediment. The limitation of this is approach is that for spot sampling 248 
of water, for example, temporal and spatial fluctuations can be considerable and are 249 
unlikely to be representative of a chronic exposure scenario. Alternatively, passive 250 
sampling that represents a time-weighted average concentration is generally 251 
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considered semi-quantitative [26]. Furthermore, these measurements do not 252 
accurately represent the real risk to aquatic wildlife as they do not account for 253 
bioavailability and it is the internalised xenobiotic concentration that will be the initiating 254 
event for any adverse effects. As such, biomonitoring campaigns are now receiving 255 
more attention for their importance in determining exposure and hazard [6, 27].  256 
Both water and biota samples were collected across 15 sites in the county of 257 
Suffolk. The 15 sites covered 5 different river catchments including Gipping, Alde, 258 
Deben, Stour and Waveney. Across the 67 compounds determined, concentrations of 259 
compounds were generally very low in both biota samples (parts per billion range) and 260 
water samples (parts per trillion range). For biota samples (n = 66), the average 261 
concentration determined was 4.3 ±5.2 ng g-1, with maximum and minimum 262 
concentrations of 45.5 ng g-1 (propranolol) and 0.2 ng g-1 (acetamiprid), respectively 263 
(Figure 3). In comparison to surface water samples, concentrations averaged 23.8 264 
±54.9 ng L-1, with the maximum and minimum concentrations of 382.2 ng L-1 (tramadol) 265 
and 0.1 ng L-1 (nordiazepam), respectively (Figure 4). In general, Site 1 in the Deben 266 
catchment showed increased concentrations of compounds such as ketamine, 267 
carbamazepine and citalopram compared to the other sites within the same catchment 268 
and between the remaining catchments. These higher concentrations also coincide 269 
with higher concentrations in surface water for compounds such as ketamine, 270 
carbamazepine and tramadol, the source of which is unclear but for these compounds 271 
their removal at WWTPs is low [28]. Debenham is a large village of 2200 inhabitants 272 
(Figure 1) served by a small WWTP upstream of the sample site. The sources for 273 
these contaminants are likely to be related to public consumption and output through 274 
WWTP effluents (for pharmaceuticals, drugs of abuse and illicits). A previous study 275 
that has quantified related compounds in influent and effluent samples from a WWTP 276 
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in London showed that the concentrations in the surface water determined here are in 277 
the range of those determined in effluent (~10 – 50 ng L-1) [28]. Additionally, spread of 278 
sludge and bio-solids including [29] reclaimed wastewater for irrigation from WWTPs 279 
onto agricultural land could lead to further surface run-off or leaching of 280 
pharmaceuticals and controlled substances into surface waters [30]. For pesticides, 281 
run-off and leaching (including possible re-mobilisation) are the potential sources 282 
relating the compounds detected herein [31].   283 
 284 
3.2.1 Illicit drugs, drugs of abuse and life-style related compounds 285 
Interestingly, the most frequently detected and highest concentration compounds in 286 
biolgoical samples were illicit drugs and/or drugs of abuse, such as cocaine, ketamine, 287 
alprazolam and diazepam. Cocaine was detected and quantified in all biota samples 288 
across all 15 sites at an average of 5.9 ± 4.3 ng g-1 (max. 30.8 ng g-1). Average 289 
concentrations of cocaine between different catchments did not vary significantly 290 
showing widespread contamination (Alde = 6.9, Deben = 6.9, Gipping = 6.8, Stour = 291 
6.2 & Waveney = 4.2 ng g-1). Lidocaine was the second most frequently detected 292 
compound in the biota samples that can be used as an adulterant to ‘cut’ cocaine due 293 
to its synergistic effects [32] or is used as local anaesthetic. Another commonly used 294 
adulterant for cocaine use is levamisole. This compound, however, was not frequently 295 
detected in either biota or surface water samples. However, illicit compounds are 296 
rarely monitored in aquatic fauna, with only one previous occurrence study in the 297 
literature that determined cocaine at an average concentration of 0.28 ng g-1 dw in 298 
Mytilus spp [3]. A separate investigation into the bioaccumulation potential of cocaine 299 
in European eels (Anguilla anguilla) in Italy revealed tissue concentrations ranging 300 
from 0.47 – 30.5 pg g-1 ww depending on tissue type at an exposure concentration of 301 
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20 ng L-1 [33]. However, eels were not studied as part of this or previous works in our 302 
laboratory. The source of the widespread cocaine contamination is unclear. Scattered 303 
throughout the catchments of these Suffolk rivers are small wastewater treatment 304 
plants that will discharge into the water courses. However, secondary wastewater 305 
treatment with activated sludge are efficient at removing cocaine (~90% [34]), whereas 306 
trickling filters are less efficient (35-37% removal [34]). The dispersal of deactivated 307 
sewage sludge onto farmland as a fertiliser is unlikely to be a primary source and 308 
concentrations of cocaine in sludge have been reported as low, at ~3 ng g-1 [35]. The 309 
primary metabolite of cocaine, benzoylecgonine (BZE) was also frequently detected, 310 
but often below the LOQ in both water and biological extracts. The concentration of 311 
cocaine determined in surface water samples was also below the LOQ for all sites and 312 
previous studies in the UK have often determined cocaine at ~1-10 ng L-1 in surface 313 
water [28, 36]. The ratio between cocaine to BZE is also important to consider and 314 
may potentially indicate the source of input into the environment. For example, in 315 
wastewater analysed from London in 2014, the ratio between cocaine and BZE was 316 
0.51 ±0.09 in influent, but was very different and more variable in effluents measured 317 
on the same days (2.60 ±1.46) [28]. Therefore, it is expected that the ratio between 318 
cocaine and BZE in river water catchments should be similar to effluent ratios but this 319 
was not the case for London, where the ratio for cocaine:BZE over six weeks of daily 320 
monitoring was 0.21 ±0.1 (similar to influent ratios) [28]. Thus, it is proposed that the 321 
input of cocaine into surface waters in the UK is likely due to combined sewer overflow 322 
events or leakage from sewer misconnections and cesspit overflow. Interestingly, the 323 
ratio in the biota samples measured here (mean: 5.00) indicated that cocaine had 324 
preferential accumulation over its demethylated metabolite, BZE.  325 
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 Tramadol was frequently detected in surface water and reached the highest 326 
measured concentration across the sites of 382.2 ng L-1. This compound has 327 
previously been detected in UK rivers ranging from <30 ng L-1 to 5970 ng L-1 [28, 36]. 328 
Effect assessments studies demonstrate lowest observed effects concentrations 329 
(LOEC) of 10 µg L-1 in fish embryo tests [37]. Occurrence of this compound here was 330 
infrequent with a maximum measured concentration of 7.5 ng g-1. Field-derived 331 
bioaccumulation studies have suggested that bioaccumulation is low with BAFs <5 332 
and tissue concentrations in fish were <6 ng g-1 [38]. Ketamine was also frequently 333 
detected in biolgocal and surface water samples here, with concentrations reaching 334 
up to 22.5 ng g-1 and 205 ng L-1. However, to the authors’ knowledge, ketamine has 335 
not been previously reported in aquatic fauna, but surface water concentrations have 336 
been measured at 12 ng L-1 [28].  337 
The benzodiazepines are a class of compounds used for medicinal purposes 338 
but are also misused/abused. Alprazolam, diazepam and temazepam was determined 339 
at 2.7 ±1.3 ng g-1, 1.5 ±1.4 ng g-1 and 2.4 ±2.3 ng g-1, respectively. Lorazepam, 340 
oxazepam and nordiazepam were infrequently detected. Our previous work has 341 
shown that diazepam and temazepam have a low potential to accumulate in G. pulex 342 
and which are capable of rapid biotransformation and elimination of these compounds 343 
[39]. In surface water samples, diazepam was infrequently detected and often 344 
occurred at <1 ng L-1. Alprazolam was also infrequently detected and below the LOQ. 345 
The average concentrations of the remaining benzodiazepines were 9.0 ±9.4 ng L-1 346 
(temazepam), 5.2 ±3.5 ng L-1 (oxazepam), 4.8 ±3.3 ng L-1 (lorazepam) and 2.2 ±0.8 347 
ng L-1 (nordiazepam).  348 
 Synthetic cathinones including methedrone, mephedrone, methcathinone and 349 
4-fluoromethcathinone were not detected at any site in the biota samples. However, 350 
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methcathinone was detected below the LOQ at a small number of sites in surface 351 
water samples from the river catchments of Waveney, Deben and Alde. Cathinones 352 
are psychoactive substances and their consumption across the UK and Europe formed 353 
the basis of several occurrence studies in surface water and wastewater [40]. Nicotine 354 
was determined in surface water samples up to 342.8 ng L-1 and was also detected in 355 
38 % of the biota samples ranging from <LOQ to 16.5 ng g-1. Its primary metabolite, 356 
cotinine, was also detected in biota and surface water samples, but less frequently 357 
and at lower concentrations. Based on human metabolism, the expected ratio of 358 
nicotine to cotinine would range between 0.65 – 1.00 [41]. However, for surface water 359 
samples the average ratio of nicotine:cotinine was 7.61 and in biota samples was 2.39. 360 
The higher concentration of nicotine to cotinine has been reported previously for 361 
effluent wastewater [42] and a similar ratio to surface water can be estimated (6.3) 362 
from reported concentrations in influent wastewater samples [43]. These types of 363 
compounds are useful to monitor in the environment as they can serve as indicators 364 
of population health and lifestyle choices. Previous studies have identified markers of 365 
alcohol consumption such as ethyl sulfate [44]. Whilst other sewage epidemiology 366 
studies have used drug concentrations in wastewater to relate back to recreational 367 
drug use of the population [45]. In addition to the association with human health, these 368 
drugs are often not monitored in biota and so any potential risk from exposed aquatic 369 
wildlife is poorly understood. The reason for poor exposure and hazard assessment is 370 
likely to stem from that many of these substances are also medicines and therefore 371 
will be considered ‘legacy’ products, which do not require ERA. Interestingly, seven of 372 
the top ten most frequently detected compounds in biota samples are related to illicit 373 
drugs/drugs of abuse. The risk of these compounds is not well understood due to the 374 
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lack of literature, but as these compounds are all psychoactive, any effects on fauna 375 
may be elicited through behavioural changes [46, 47]. 376 
 377 
3.2.2 Pharmaceuticals 378 
The most frequently detected pharmaceutical in both biota and surface water samples 379 
was carbamazepine. This compound has been shown to occur in G. pulex, surface 380 
water and sludges samples [5, 29]. Measured concentrations in the biota samples 381 
ranged from <LOQ to 31.5 ng g-1 and in surface water, the concentrations ranged from 382 
<LOQ to 272 ng L-1. The highest surface water concentrations were measured at Site 383 
1 (average: 225 ng L-1) which also corresponded to relatively high concentrations 384 
measured in G. pulex with an average of 16.3 ng g-1. Higher concentrations of 385 
carbamazepine were determined at site 6 and 8 for the Ephemera vulgata and Asellus 386 
aquaticus samples. Site 8 surface water concentration of carbamazepine were below 387 
the LOQ and site 16 averaged 92.6 ng L-1. This may suggest that E. vulgata and A. 388 
aquaticus are more sensitive than G. pulex to the accumulation of carbamazepine. 389 
However, surface water concentrations often do not translate well into internal 390 
concentrations for several reasons such as temporal variation, spatial variation and 391 
migration behaviour of aquatic fauna among other influences. Additionally, the main 392 
human metabolite of carbamazepine, CBZ-epoxide, was detected across 30% of the 393 
biota samples. This metabolite has been detected and measured in invertebrate 394 
species including G. pulex and Mytilus galloprovincialis showing conservation of 395 
biotransformation pathways [39, 48]. The increased concentration of carbamazepine 396 
at Site 1 G. pulex samples also coincided with increased detection of the epoxide 397 
metabolite. However, the metabolite was not detected in E. vulgata larvae and was 398 
minimal in A. aquaticus despite higher concentrations of carbamazepine measured in 399 
19 
 
these species. This may indicate a different sensitivity of these organisms to 400 
carbamazepine through toxicokinetics, where biotransformation and elimination routes 401 
are different. The mean ratio of carbamazepine to the epoxide metabolite was 8.9 in 402 
the biota samples, which is closer to observed human therapeutic ratios of ~5 [49].  403 
 The highest measured pharmaceutical concentration across the biota samples 404 
alone was for the beta-blocker propranolol (45.5 ng g-1 at Site 4). The concentrations 405 
of propranolol in surface water ranged from <LOQ to a maximum of 27 ng L-1, which 406 
is significantly below (two orders of magnitude) the reported no-observed effects 407 
(NOEC) and lowest-observed effects (LOEC) in fish and invertebrates [50, 51]. Other 408 
beta-blockers were detected at lower concentrations and less frequently which 409 
included betaxolol, salbutamol and metoprolol. The remaining beta-blockers included 410 
in this method, were not detected at any site for the biota samples (timolol, nadolol 411 
and bisoprolol). However, for surface water samples, bisoprolol was detected 412 
frequently across all river catchments, with metoprolol and the beta-agonist salbutamol 413 
less frequently detected.  414 
 The selective serotonin reuptake inhibitor citalopram was frequently detected 415 
in biota samples at Site 7, Site 1 and Site 20, with concentrations ranging from 3.8 to 416 
36.6 ng g-1. The maximum concentration was determined to be 42.4 ng g-1 at Site 14. 417 
Surface water concentrations of citalopram were often below the LOQ but were 418 
determined at higher average concentrations of 14.7±10.6 ng L-1 for Site 1, Site 7 and 419 
Site 20. Citalopram has been previously determined up to concentrations of 20.6 ng 420 
g-1 in bivalves (Mytilus spp.) [52], 0.212 ng g-1 in fish brain tissue (Catostomus 421 
commersonii) [53] and more recently was reported to reach concentrations of ~6000 422 
ng g-1 in Hydropsyche spp [54]. From the literature, citalopram has been observed to 423 
have low accumulation factors ranging from less <7 to 47 [38, 55]. Based on 424 
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occurrence data presented here, it would also likely have a low bioaccumulation factor. 425 
Furthermore, the analytical method here could not distinguish between the 426 
enantiomeric forms of citalopram with the S-enantiomer responsible for the 427 
pharmacological action where it has also been suggested that R-enantiomer inhibits 428 
this therapeutic effect. Other researchers have shown that racemic mixtures of 429 
pharmaceuticals can often be enriched by either human or microbial biotransformation 430 
or may remain as racemates if biodegradation does not occur [56]. Many of the 431 
pharmaceuticals reported here display stereoisomerism, which is poorly understood 432 
in terms of environmental risk, and is often overlooked in both fate and effect-based 433 
studies [56]. The most frequently detected antibiotic was trimethoprim with measured 434 
concentrations ranging from 1.5 – 4.6 ng g-1. Other antibiotics detected included three 435 
sulphonamides: sulfamethazine; sulfapyridine; and sulfadimethoxine. However, 436 
sulfamethazine was not quantifiable in any sample and sulfadimethoxine was only 437 
measured once reaching 1.7 ng g-1. Bioconcentration studies for sulfamethazine in 438 
Oryzias melastigma have ranged from <1 – 145 depending on tissue and biological 439 
sex indicating that there is no or little potential for bioaccumulation [39, 57]. The low 440 
bioaccumulation is likely to stem from the polarity (logP = 0.44, logD8 = 0.1) and 441 
ionisation state of the drug which has been shown to influence uptake in fish and 442 
invertebrates [20, 58, 59]. Sulfapyridine, was also infrequently detected except at Site 443 
1, with an average concentration of 4.8 ng g-1. The low occurrence of the 444 
sulphonamides in biota is likely due to the high polarity and metabolism of these 445 
compounds.   446 
 447 
3.2.3 Pesticides 448 
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Neonicotinoids have gained much attention recently, with the EU now enforcing a near 449 
total ban on their use [60]. Few studies have determined the presence of these 450 
compounds in aquatic fauna [6, 27]. Other studies have targeted these pesticides in 451 
fish, but ultimately were not detected [7, 8]. However, these compounds do occur in 452 
surface water and averaged at 130 ng L-1 across 19 studies [61]. The compounds 453 
thiacloprid and acetamiprid were infrequently detected in surface water samples 454 
across all sites here and remained below the LOQ. Imidacloprid was not detected at 455 
any site. This agreed with a recent report on neonicotinoid contamination in UK surface 456 
waters [62], which summarised that thiacloprid and acetamiprid showed low 457 
contamination which is likely related to their low use as opposed to other 458 
neonicotinoids such as clothiandin and thiamethoxam. The qualitative data showed 459 
thiamethoxam was not detected across any sites and clothiandin was infrequently 460 
detected. This contrasts data reported for thiamethoxam in the river Waveney which 461 
showed concentrations reaching up to 1.03 µg L-1 and an average concentration of 462 
~60 ng L-1. A possible reason for the disparity between the data reported here is that 463 
the previous report was from a monitoring campaign in 2016. The samples collected 464 
in the present study were from July  2018, following the driest period record with no 465 
rain in the previous 55 days [63] suggesting that input from surface run-off and 466 
leaching was likely to be minimal. Furthermore, thiamethoxam use (area treated of 467 
arable crops) peaked in 2012 and has been followed by a decrease up to 2016 [62]. 468 
For the biota samples, acetamiprid was infrequently detected in the Waveney, but 469 
consistently detected in the catchments of Alde, Deben, Gipping and Stour. However, 470 
this compound was often below the LOQ and upon quantification showed 471 
concentrations ranging from 0.2 – 0.7 ng g-1. Thiacloprid was frequently measured in 472 
the river Waveney and Deben with average concentrations of 3.3 ± 1.6 ng g-1 and 1.6 473 
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± 1.7 ng g-1. With so little data available, meaningful comparisons of neonicotinoid 474 
concentrations with other pesticides in biota samples is difficult. Nonetheless, 475 
concentrations measured here were in the range to that of a previous investigation 476 
with thiacloprid ranging from LOQ – 21 ng g-1. Out of 10 pesticides that no longer have 477 
approval in the EU [64], a total of seven were detected in biota samples here (ametryn, 478 
dimethametryn, fenuron, propazine, aclonifen and oxycarboxine), including three that 479 
were quantifiable (ametryn, dimethametryn, fenuron). The most widespread 480 
occurrence corresponded to fenuron (0.7 – 16.1 ng g-1), oxycarboxine (qualitative) and 481 
ametryn (LOQ – 1.9 ng g-1). The compound oxycarboxine was detected with 100 % 482 
frequency (Table S5) and fenuron with 86 % frequency in biota samples. Detection of 483 
banned pesticides has recently been reported with atrazine (banned since 2003) 484 
quantified in 63 % of samples [65]. However, there is little occurrence data available 485 
for the banned pesticides detected here, but several banned pesticides including 486 
fenuron, atrazine and simazine have been found to occur in UK groundwaters [66]. 487 
The detection of these compounds in the environment might be explained by 488 
persistence and subsequent release of these compounds in sediments and/or soil [65].  489 
 490 
3.3 Estimating the toxic or effect pressure of contaminants in the aquatic environment 491 
It has been suggested that internalised concentrations of contaminants are more 492 
appropriate for the assessment of potential risk in the environment than effect 493 
thresholds based on external exposure (i.e. in the water) [1]. From the data here, we 494 
estimated the internal toxic pressure (pesticides) or ‘effect pressure’ 495 
(pharmaceuticals/drugs of abuse) [6] using predicted bioconcentration data [20, 21] 496 
and the available effect data (EC50 or CEC) [18, 24]. This approach is analogous to 497 
risk quotients (RQ) estimated from predicted environmental concentrations and 498 
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predicted no effect concentration (PEC/PNEC). The logTUint for the pesticides 499 
determined ranged from approximately -7 to -2 (Figure 5a), where previous studies 500 
have indicated that a logTU threshold based on water concentrations for pesticides of 501 
-3 and higher can elicit adverse effects [13-15], Only one compound (oxamyl) was 502 
above the threshold of logTU ≥ -3. This compound is still approved for use in the EU 503 
and may indicate the potential for risk at the concentrations measured in the biota 504 
samples. The EC50 was based on D. magna acute toxicity studies which have been 505 
shown to be the most sensitive across all aquatic organisms that were tested. 506 
However, the risk based on available evidence was concluded to be low [67]. The 507 
neonicotinoids acetamiprid and thiacloprid showed low logTUint values of less than -508 
4.6. In comparison, Munz et al. [6] estimated thiacloprid to have a higher logTUint in G. 509 
pulex than reported here and exceeded the threshold for several of the measured 510 
samples. The disparity between the estimation of toxic pressure is that concentrations 511 
of thiacloprid determined here in G. pulex, were relatively lower. In addition, the EC50 512 
value used in this study was ~10-fold larger than in the previous study. For this 513 
approach EC50 data is often not well distributed and can vary depending on the end 514 
point, experimental conditions and species used. For these reasons, it may be more 515 
appropriate to include a range of the EC50 data available or review the quality of the 516 
available literature data to give more reliable estimation of toxic pressure [68].  517 
 The logTU threshold value is not likely to be directly applicable to 518 
pharmaceuticals, which are likely to be less toxic than pesticides by nature of their 519 
design. Thus, for this work we use the term ‘effect units’ (EUint) for pharmaceuticals, 520 
as thresholds that might be associated to toxicity are unknown. Instead, CEC data are 521 
used instead of EC50int, but in themselves are not a toxicity endpoint. Substantial 522 
further work would be needed to determine possible thresholds associated with TU for 523 
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different contaminant classes and for internalised concentrations, as opposed to 524 
surface water concentrations. Larger effect pressures were mainly associated with 525 
pharmaceuticals such as haloperidol that showed the highest EUint (Figure 5b). The 526 
reason haloperidol has high EUint values is due to the low CEC of 6.5 ng L-1 based on 527 
human therapeutic plasma concentrations of 1 ng mL-1. Additional antipsychotic drugs 528 
including chloropromazine (CEC = 36 ng L-1) and risperidone (CEC = 129 ng L-1) were 529 
also estimated to have a high toxic pressure. Other neuroactive pharmaceuticals 530 
including antidepressants and anxiolytics such as alprazolam, lorazepam, citalopram 531 
and busipirone also showed higher EUint which may indicate that these types of 532 
contaminants have a greater risk in the environment which has been previously 533 
suggested from surface water risk assessments [69]. This may be particularly 534 
apparent when focussing on sub-lethal endpoints such as altered behaviour 535 
phenotypes [70]. Despite its widespread occurrence, cocaine showed a low potential 536 
for an effect based on its CEC and BCF. The benefits of using CECs for 537 
pharmaceuticals is that the availability of data for human therapeutic values is greater 538 
than ecotoxicological data. In particular, EC50 data for ‘legacy’ pharmaceuticals is 539 
critically lacking. However, the use of CECs has some limitations in that a therapeutic 540 
effect does not necessarily correspond to an adverse effect and that the onset of 541 
pharmacological action may differ between humans and non-target organisms [18, 542 
71]. Furthermore, molecular targets of pharmacological action are not always 543 
conserved between species and bioavailability may also differ between them [19, 71].  544 
 545 
4. Conclusion 546 
Cocaine was the most widespread contaminant found in both surface water and biota 547 
samples, but no conclusions can be drawn about the potential for adverse effects of 548 
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this compound without further work. Out of 67 compounds that could be quantitatively 549 
determined 56 were measured with the higher frequencies of detection for cocaine 550 
(100%), lidocaine (95%), alprazolam (88%), fenuron (86%) and ketamine (76%) in 551 
biota samples. In comparison for surface water samples, 50 compounds were 552 
measured including cocaine, carbamazepine, fenuron, ketamine and lidocaine, 553 
propranolol and tramadol that all had 100% detection frequency. The detection of 554 
several pesticides that no longer have approval in the EU warrants further 555 
investigation, as the sources for their input into the environment remain unclear. The 556 
total body burden of the contaminants determined in the biota samples ranged from 557 
6.5 ng g-1 to 163.5 ng g-1 dw depending on the site. The total body burden is also an 558 
underestimate when accounting for the qualitative data, in addition to contaminants 559 
that were not targeted for in this study (including biotransformation products). Overall, 560 
whilst toxic pressure and effect pressure estimates were low in this study, the 561 
contribution of total body burden, the variability in effect data available (including lack 562 
of internal effect data) and thresholds for toxic/effect pressure are limitations to 563 
improving environmental risk assessment based on this approach. Nevertheless, the 564 
approach does support prioritisation of contaminants in the environment through the 565 
use of biomonitoring to reveal both the exposure, hazard and, ultimately, risk.  566 
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Table 1:  Method performance assessment for G. pulex covering all stages of the analytical workflow. Repeatability was assessed 
by intra-day (3 concentrations) and inter-day precision (1 concentration) and is expressed by relative standard deviation (RSD). 
Matrix effects were assessed at 50 ng g-1 (n=5) by comparing post-extraction spiked matrix matched standards to a pure analytical 
standard and negative values indicate suppression effects.      
 
Matrix Effect Recovery Inter-day LOQ LOD






 Precision (%RSD)  25 ng g
-1













4-fluoromethcathinone -44 ± 5 6.92 ± 0.014 45 14 13 14 19 75 ± 12 92 ± 30 117 ± 15 0.9930 3.7-500 3.7 1.2
Acetamiprid -57 ± 8 6.92 ± 0.001 92 1 15 7 9 102 ± 1 98 ± 6 96 ± 7 0.9997 0.2-500 0.2 0.08
Alprazolam -46 ± 10 10.58 ± 0.011 71 8 7 6 13 80 ± 7 80 ± 12 90 ± 6 0.9976 1.2-250 1.2 0.4
Ametryn -62 ± 8 11.76 ± 0.002 80 12 8 8 7 72 ± 9 111 ± 8 96 ± 12 0.9950 1.3-250 1.3 0.4
Antipyrin -52 ± 6 5.43 ± 0.001 72 1* 10 7 16 84 ± 11 125 ± 17 126 ± 9 0.9973 6.8-500 6.8 1.4
Benzotropine -70 ± 8 11.89 ± 0.002 65 9 5 6 15 74 ± 7 106 ± 12 97 ± 5 0.9901 0.6-250 0.6 0.2
Benzoylecgonine -58 ± 2 4.65 ± 0.017 71 4 7 8 15 102 ± 9 95 ± 11 116 ± 0 0.9982 0.6-500 0.6 0.2
Betaxolol -53 ± 8 10.29 ± 0.014 94 3 11 3 22 100 ± 18 88 ± 18 80 ± 4 0.9944 0.5-250 0.5 0.2
Bezafibrate -61 ± 6 6.96 ± 0.016 63 8 13 6 15 89 ± 12 97 ± 7 108 ± 6 0.9984 9.2-500 9.2 3.0
Bisoprolol -28 ± 17 9.54 ± 0.066 93 5 6 10 13 85 ± 1 101 ± 12 86 ± 8 0.9898 0.9-250 0.9 0.3
Busipirone -50 ± 9 11.26 ± 0.002 76 7 3 6 11 105 ± 14 97 ± 11 102 ± 12 0.9956 1.1-500 1.1 0.4
Carbamazepine -48 ± 8 9.59 ± 0.001 67 15 5 8 14 92 ± 11 86 ± 11 101 ± 4 0.9971 0.9-500 0.9 0.3
CBZ_epoxide -38 ± 3 7.70 ± 0.001 85 2 12 5 16 92 ± 2 113 ± 13 89 ± 6 0.9988 0.6-500 0.6 0.2
Chloropromazine -82 ± 5 12.66 ± 0.008 91 11 5 12 *12 99 ± 11 98 ± 28 140 ± 8 0.9928 1.8-500 1.8 5.5
Citalopram -71 ± 5 10.62 ± 0.001 76 11 10 13 24 82 ± 15 107 ± 15 78 ± 11 0.9974 2.6-250 2.6 0.9
Cocaine -37 ± 7 9.97 ± 0.014 80 8 2 1 9 96 ± 7 90 ± 11 114 ± 12 0.9973 0.5-500 0.5 0.2
Cotinine 30 ± 8 3.78 ± 0.011 62 15 8 3 13 93 ± 21 78 ± 19 109 ± 3 0.9986 2.6-500 2.6 0.8
Cycluron -34 ± 13 10.73 ± 0.002 77 2 5 7 8 109 ± 2 100 ± 8 104 ± 7 0.9997 1.5-500 1.5 0.5
Diazepam -60 ± 10 11.95 ± 0.002 87 9 11 8 13 86 ± 6 87 ± 10 88 ± 7 0.9963 0.3-250 0.3 0.1
Dimethmetryn -50 ± 10 13.02 ± 0.011 76 5 10 7 7 86 ± 3 89 ± 2 121 ± 8 0.9958 0.1-250 0.1 0.03
Diphenydramine -51 ± 9 10.94 ± 0.011 76 12 12 10 16 94 ± 11 111 ± 16 92 ± 8 0.9936 1.8-250 1.8 0.6
Ethirimol -81 ± 4 8.93 ± 0.015 81 10 9 11 11 89 ± 6 87 ± 7 94 ± 9 0.9935 1.7-500 1.7 0.6
Fenuron -56 ± 9 6.25 ± 0.016 79 9 10 3 11 105 ± 12 117 ± 10 94 ± 3 0.9991 0.6-500 0.6 0.2
Flutamide -42 ± 16 12.27 ± 0.002 80 9 7 2 16 90 ± 5 96 ± 11 75 ± 1 0.9942 0.2-250 0.2 0.1
Haloperidol -79 ± 7 11.26 ± 0.002 83 2 5 6 16 104 ± 2 92 ± 17 113 ± 8 0.9935 5.3-250 5.3 1.8
Hyrochlorothiazide -77 ± 2 3.90 ± 0.011 77 5* 13 2 19 100 ± 33 85 ± 16 118 ± 13 0.9952 2.1-500 2.1 0.7
Ketamine -56 ± 6 11.00 ± 0.002 54 10 5 7 9 85 ± 8 94 ± 2 110 ± 13 0.9949 1-500 1.0 0.3
Ketoprofen 10 ± 11 6.21 ± 0.001 69 15 9 10 14 106 ± 12 90 ± 8 117 ± 11 0.9970 15.3-500 15.3 5.0
Ketotifen -55 ± 11 10.74 ± 0.002 70 11 8 10 16 81 ± 6 104 ± 16 99 ± 10 0.9955 3.9-250 3.9 1.3
Levamisole -58 ± 4 7.76 ± 0.014 61 12 8 6 13 116 ± 13 83 ± 6 118 ± 7 0.9894 4.0-500 4.0 1.3
Levocabastine -42 ± 8 8.16 ± 0.015 97 16 10 6 15 71 ± 8 97 ± 6 113 ± 6 0.9934 0.3-250 0.3 0.1
Lidocaine -46 ± 6 11.46 ± 0.002 67 1 7 7 13 104 ± 1 91 ± 8 115 ± 8 0.9956 0.7-500 0.7 0.2
Lincomycin -18 ± 5 7.80 ± 0.009 82 5 4 9 11 112 ± 9 93 ± 8 100 ± 10 0.9968 4.5-500 4.5 1.5
Lorazepam -26 ± 14 10.44 ± 0.013 71 12 10 8 22 81 ± 6 85 ± 9 118 ± 8 0.9895 1.9-250 1.9 0.6
MDMA -59 ± 6 6.10 ± 0.042 64 6 9 10 16 111 ± 7 101 ± 9 97 ± 9 0.9995 1.9-500 1.9 0.6
Mephedrone -12 ± 6 7.65 ± 0.031 69 12 6 9 14 95 ± 8 72 ± 13 91 ± 3 0.9943 10.5-500 10.5 3.5
Mephosfolan -49 ± 12 11.52 ± 0.002 69 7 9 12 7 91 ± 14 91 ± 3 98 ± 11 0.9934 1.4-500 1.4 0.4
Methamphetamine -61 ± 5 6.25 ± 0.061 65 4 12 1 12 109 ± 16 123 ± 17 115 ± 10 0.9981 1.7-500 1.7 0.6
Methcathinone -56 ± 1 6.24 ± 0.016 43 9 13 2 15 83 ± 6 83 ± 10 117 ± 19 0.9856 3.9-250 3.9 1.3
Methedrone -63 ± 3 6.56 ± 0.015 73 1 9 15 11 70 ± 1 122 ± 8 93 ± 15 0.9991 2.9-500 2.9 1.0
Methylphenidate -74 ± 3 9.31 ± 0.055 84 15 5 10 11 89 ± 11 100 ± 15 88 ± 8 0.9944 0.2-250 0.2 0.05
Metoprolol -81 ± 12 7.64 ± 0.051 84 13 14 5 20 81 ± 11 89 ± 9 100 ± 5 0.9929 2.8-500 2.8 0.9
Nicotine 59 ± 17 6.18 ± 0.032 51 10 8 13 13 73 ± 12 115 ± 23 91 ± 21 0.9859 2.6-250 2.6 0.9
Nadolol -20 ± 10 5.13 ± 0.022 77 5 12 13 12 106 ± 18 99 ± 2 112 ± 10 0.9949 2.2-500 2.2 0.7
Nordiazepam -13 ± 24 11.18 ± 0.016 78 7 13 15 15 95 ± 5 83 ± 9 108 ± 5 0.9972 2.4-250 2.4 0.8
Oxamyl -20 ± 23 6.17 ± 0.001 90 11 14 18 16 124 ± 33 113 ± 25 100 ± 19 0.9956 1.9-500 1.9 0.6
Oxazepam -10 ± 19 10.19 ± 0.012 86 15 12 1 18 81 ± 15 122 ± 14 76 ± 1 0.9948 3.2-250 3.2 1.1
Pirenzipine -41 ± 2 5.33 ± 0.016 74 5 3 7 17 82 ± 7 97 ± 11 119 ± 13 0.9917 0.4-500 0.4 0.1
Prometon -51 ± 11 11.22 ± 0.002 71 5 2 9 7 92 ± 4 104 ± 7 100 ± 9 0.9971 0.9-500 0.9 0.3
Propamocarb -65 ± 8 5.20 ± 0.022 47 3* 8 1 8 64 ± 5 63 ± 5 92 ± 13 0.9934 0.6-500 0.6 0.2
Propazine -43 ± 8 11.85 ± 0.015 70 7 12 6 13 102 ± 9 80 ± 3 93 ± 19 0.9919 3.5-250 3.5 1.2
Propranolol -56 ± 12 9.96 ± 0.015 76 19 15 5 19 74 ± 5 74 ± 10 107 ± 6 0.9990 7.1-250 7.1 2.4
Risperidone -76 ± 4 10.28 ± 0.001 73 1 8 5 15 101 ± 5 104 ± 12 100 ± 1 0.9924 0.4-500 0.4 0.1
Rizatriptan -47 ± 5 4.69 ± 0.021 55 14 14 8 13 101 ± 13 118 ± 6 122 ± 9 0.9955 3-500 3.0 1.0
Salbutamol 7 ± 10 3.30 ± 0.016 26 13 10 15 24 88 ± 16 96 ± 13 117 ± 16 0.9987 7-500 7.0 2.0
Sulfadimethoxine -80 ± 3 4.37 ± 0.016 76 15 7 6 17 87 ± 20 87 ± 6 124 ± 30 0.9986 0.9-500 0.9 0.3
Sulfamethazine -75 ± 3 4.70 ± 0.011 78 6 12 10 23 90 ± 13 76 ± 15 118 ± 12 0.9981 1-500 1.0 2.9
Sulfapyridine -61 ± 7 4.27 ± 0.014 77 6 15 12 17 108 ± 3 92 ± 15 125 ± 3 0.9873 3-500 3.0 1.0
Tacrine -72 ± 4 6.51 ± 0.060 70 5 12 11 15 93 ± 5 104 ± 20 85 ± 10 0.9912 1.6-500 1.6 0.5
Tamsulosin -39 ± 14 9.91 ± 0.001 78 1 15 16 17 72 ± 4 121 ± 12 84 ± 12 0.9976 2.6-500 2.6 0.8
Temazepam -33 ± 12 11.13 ± 0.002 81 9 6 9 13 109 ± 7 88 ± 10 100 ± 9 0.9936 0.5-500 0.5 0.2
Thiacloprid - - 7.09 ± 0.015 100 7 11 3 9 119 ± 9 83 ± 7 117 ± 3 0.9993 0.2-500 0.2 0.07
Timolol -45 ± 3 7.24 ± 0.050 72 15 12 10 16 73 ± 14 98 ± 21 107 ± 10 0.9940 25.2-250 25.2 8.3
Tramadol -67 ± 9 8.53 ± 0.078 91 10 15 12 16 109 ± 12 105 ± 14 82 ± 10 0.9957 3.1-500 3.1 1.0
Trimethoprim -67 ± 5 6.06 ± 0.001 73 20 8 3 16 57 ± 20 92 ± 11 121 ± 15 0.9915 0.1-500 0.1 0.04
Verapamil -67 ± 8 12.03 ± 0.002 67 13 8 8 15 82 ± 10 109 ± 19 117 ± 9 0.9904 2.4-250 2.4 0.8
Warfarin -71 ± 4 6.17 ± 0.012 75 4 14 9 18 74 ± 3 109 ± 16 96 ± 8 0.9959 0.9-500 0.9 0.3















Figure 1: Sampling locations of collected biota and surface water samples within the 












Figure 2: Comparison of predicted logBCF data from EPI suite and ANN model, for 


























Figure 3: Heatmap of compounds determined in the biolgoical samples that showed 
acceptable method performance. G, H, A or E indicate the sampled species G. 
pulex, H. pellucidula, A. aquaticus or E. vulgata, respectively. Grey tiles indicate 





























Figure 4: Heatmap of compounds determined in the surface water samples. All sites 
were samples in triplicate except for Site 10 (n=2). Grey tiles indicate compounds 




























Figure 5: (a) Toxic pressure analysis of measured pesticides quantified by internal 
toxic units (logTU) (b) effect pressure analysis of measured pharmaceuticals and 
illicit drugs quantified by internal effect units (logEU)   
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